Skip to main content

Abeona Therapeutics: Q4 Earnings Snapshot

CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Tuesday reported a loss of $20.5 million in its fourth quarter.

On a per-share basis, the Cleveland-based company said it had a loss of 34 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.

The drug developer posted revenue of $5.4 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $5.1 million.

For the year, the company reported net income of $71.2 million, or $1.01 per share, swinging to a profit in the period. Revenue was reported as $5.8 million.

The company’s shares closed at $4.95. A year ago, they were trading at $5.29.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story